These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2967234)

  • 1. Absence of immunoreactive luteinizing hormone following gonadotropin-releasing hormone agonist therapy in women with endometriosis.
    Bischof P; Herrmann WL
    Gynecol Obstet Invest; 1988; 25(2):130-4. PubMed ID: 2967234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.
    Lahlou N; Roger M; Chaussain JL; Feinstein MC; Sultan C; Toublanc JE; Schally AV; Scholler R
    J Clin Endocrinol Metab; 1987 Nov; 65(5):946-53. PubMed ID: 2959680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
    Meldrum DR; Chang RJ; Lu J; Vale W; Rivier J; Judd HL
    J Clin Endocrinol Metab; 1982 May; 54(5):1081-3. PubMed ID: 6801075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women.
    Meldrum DR; Tsao Z; Monroe SE; Braunstein GD; Sladek J; Lu JK; Vale W; Rivier J; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):755-7. PubMed ID: 6365947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
    Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B
    J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients.
    Zorn JR; Mathieson J; Risquez F; Comaru-Schally AM; Schally AV
    Fertil Steril; 1990 Mar; 53(3):401-6. PubMed ID: 2137792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH2(10)]LH-RH ethylamide.
    Dupont A; Dupont P; Belanger A; Mailoux J; Cusan L; Labrie F
    Fertil Steril; 1990 Aug; 54(2):227-32. PubMed ID: 2199228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.
    Lerrant Y; Kottler ML; Bergametti F; Moumni M; Blumberg-Tick J; Counis R
    Endocrinology; 1995 Jul; 136(7):2803-8. PubMed ID: 7789305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin and free alpha-subunit secretion in patients during GnRH-agonist treatment.
    Lindner C; Lichtenberg V; Braendle W
    Horm Metab Res; 1991 Nov; 23(11):553-8. PubMed ID: 1840057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
    Zorn JR; Tanger C; Roger M; Grenier J; Comaru-Schally AM; Schally AV
    Int J Fertil; 1986; 31(1):11-3, 16-27. PubMed ID: 2908272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid.
    Mann DR; Collins DC; Smith MM; Kessler MJ; Gould KG
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1277-83. PubMed ID: 3097054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.
    Uemura T; Yanagisawa T; Shirasu K; Matsuyama A; Minaguchi H
    Am J Obstet Gynecol; 1992 Jul; 167(1):283-91. PubMed ID: 1332475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
    Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
    J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
    St Arnaud R; Lachance R; Dupont A; Labrie F
    J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
    Roth CL; Brendel L; Rückert C; Hartmann K
    Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
    Perl V; Marquez J; Schally AV; Comaru-Schally AM; Leal G; Zacharias S; Gomez-Lira C
    Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.